Cargando…

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study

INTRODUCTION: Most people achieve and maintain viral load (VL) suppression on first-line antiretroviral therapy (ART) but for a minority this does not happen. It is unclear whether those who have maintained VL suppression for several years will be able to continue to do so, or if rates of VL failure...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Connor, Jemma, Smith, Colette, Lampe, Fiona, Johnson, Margaret, Sabin, Caroline, Phillips, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Oral Presentation – Abstract O424
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224895/ https://www.ncbi.nlm.nih.gov/pubmed/25394036 http://dx.doi.org/10.7448/IAS.17.4.19527

Ejemplares similares

Profil épidémiologique, clinique et évolutif de la COVID-19 chez les patients hospitalisés au service de pneumologie de Blida en 2020
por: Nacef, L., et al.
Publicado: (2023)

Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC
por: May, MT, et al.
Publicado: (2010)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

Effects of age on symptom burden, mental health and quality of life amongst people with HIV in the UK
por: McGowan, Jennifer, et al.
Publicado: (2014)

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
por: O'Connor, Jemma, et al.
Publicado: (2017)

Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don't
por: Sabin, C
Publicado: (2012)

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
por: May, Margaret, et al.
Publicado: (2011)

Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study
por: Price, Huw, et al.
Publicado: (2012)

A four-month follow-up study of Cardiac performance in patients hospitalized with COVID-19 in a Tertiary Care Government Medical Hospital
por: Sayed, M.A., et al.
Publicado: (2022)

Determinants of IL-6 levels during HIV infection
por: Borges, Álvaro H, et al.
Publicado: (2014)

Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?
por: Huntington, Susie, et al.
Publicado: (2014)

Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
por: Violari, A, et al.
Publicado: (2012)

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

Industrial chic : cult furniture, design and lighting /
por: Durieux, Brigitte
Publicado: (2012)

Measurement of sigma(chic2)/ sigma(chic1) at sqrt(s) = 7 TeV
por: CMS Collaboration
Publicado: (2012)

Adverse events: ART and the kidney: alterations in renal function and renal toxicity
por: Post, Frank
Publicado: (2014)

Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK
por: Daskalopoulou, Marina, et al.
Publicado: (2016)

Measurement $\chi_c$ in CMS
por: Pronina, Elizaveta
Publicado: (2016)

Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018
por: Hill, Andrew, et al.
Publicado: (2014)

A clinically useful risk-score for chronic kidney disease in HIV infection
por: Mocroft, Amanda, et al.
Publicado: (2014)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens
por: Eron, Joseph J, et al.
Publicado: (2014)

Photon-Photon Collisions with SuperChic
por: Harland-Lang, Lucian A., et al.
Publicado: (2017)

Relative $\chi_c$ Production at LHCb
por: Kerzel, U
Publicado: (2011)

Central Exclusive \chi_c Production
por: Teryaev, Oleg V, et al.
Publicado: (2010)

Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
por: Gatell, Josep M, et al.
Publicado: (2014)

OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)
por: Routy, J, et al.
Publicado: (2009)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

When to start: as soon as possible
por: Saag, M
Publicado: (2012)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Late presenters: what can we do?
por: Mussini, C
Publicado: (2012)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Treatment optimization in low- and middle-income countries
por: Cooper, D
Publicado: (2012)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3
por: Nichols, G, et al.
Publicado: (2012)

Eliminating paediatric infections and keeping mothers alive
por: Gray, G
Publicado: (2012)

HIV in women
por: Mulcahy, F
Publicado: (2012)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

Currently available medications may not be sufficient for lifelong treatment of HIV
por: Jansson, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5hr3g336dh49mqvght2dd231st